NEW YORK (GenomeWeb) – San Diego-based Agena Bioscience today announced it has established a subsidiary in Shanghai.

"The Chinese market represents a significant portion of Agena Bioscience's global sales with almost 60 MassArray Systems installed to date," Agena CEO Pete Dansky said in a statement. "Direct presence within China will allow us to expand our reach and foster a high degree of engagement with our local customers in that region."

The firm has hired Bob Wang, a former Qiagen marketing director, to lead the Chinese subsidiary.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.